• Most Popular
  • Most Shared

Reuters Showcase

India Quarterly Growth

India Quarterly Growth

India Q4 GDP seen slowing to 6 pct, says StanChart.  Full Article 

Bharti Inks Deal

Bharti Inks Deal

India's top mobile phone carrier to buy 49 pct in Qualcomm India broadband venture  Full Article 

Troubled Rupee

Troubled Rupee

Rupee rebounds from record low; snaps losing run.  Full Article | Related Story 

Facebook IPO Fallout

Facebook IPO Fallout

Four of Wall Street's main market makers' losses total at least $100 mln  Full Article 

Aiming To Crack China

Aiming To Crack China

India's Mahindra taps Korean arm to push brand in world's largest auto market  Full Article 

Jet Airways Results

Jet Airways Results

Airline posts fifth quarterly loss.  Full Article | Related Story 

Euro Zone Crisis

Euro Zone Crisis

What would Greek exit mean for the U.S. economy?  Full Article 

Buy, Sell or Hold?

Buy, Sell or Hold?

Stock recommendations from VantageTrade.  Full Coverage 

Reuters India Mobile

Reuters India Mobile

Get the latest news on the go. Visit Reuters India on your mobile device.  Full Coverage 

Glenmark Pharma unit plans 5.75-bln-rupee IPO

Stocks

   

MUMBAI | Mon Oct 5, 2009 11:37am IST

MUMBAI Oct 5 (Reuters) - Glenmark Generics Ltd, a unit of drug maker Glenmark Pharmaceuticals Ltd (GLEN.BO), plans to raise 5.75 billion rupees through an intial public offer (IPO) of shares, according to a preliminary filing with the regulator.

The company plans to raise upto 1 billion rupees through a pre-IPO sale of shares, Glenmark added in its draft red herring prospectus filed with the Securities and Exchange Board of India last week.

Enam Securities and Kotak Mahindra Capital Co will manage the issue, the proceeds from which will be used to part pay loans and for general corporate purposes, it added. (Reporting by Bharghavi Nagaraju; Editing by Sunil Nair)

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.